Skip to main content

New Transcription Factors and Their Role in Diabetes and Therapy

  • 1st Edition, Volume 5 - August 10, 2006
  • Latest edition
  • Editor: Jacob E. Friedman
  • Language: English

This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with… Read more

Happy World Book Day

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may underline the pathogenetic mechanisms of diabetes and obesity. Volume 5 provides an overview of the status of the field, while also providing valuable information of practical utility to those who do not necessarily work in this field. The integration of basic biology with physiologically and clinically relevant proteins should provide the reader with a theoretical background to understanding the strategies for new potential therapeutic targets and their application to disease.

Key features

*Applies molecular biology to transcriptional regulation of metabolism and obesity
*Underscores the clinical relevance of transcription factors
*Provides a valuable overview of the current status of the field

Readership

Endocrinologists, Biomedical researchers, Geneticists, Molecular and Cellular Biologists

Table of contents

1. PPARs as therapeutic targets for treating diabetes and insulin resistance

2. Genetic regulators of human obesity and diabetes

3. NF-kb, insulin resistance and the actions of salicylates

4. Wnt signaling and C/EBPs role in adipogenesis

5. Regulation of hepatic gluconeogenesis C/EPBs

6. Forkhead proteins and regulation of hepatic gene expression

7. Control of mitochondrial biogenesis through PGC-1

8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications

9. FOXC2 controls resistance to obesity and Type II diabetes

10. SREB-1C regulation of nutrient homeostasis and lipid accumulation

11. GATA proteins as molecular gatekeeprs of the adipocyte

12. Diabetes regulation of gene expression by CREB

13. Molecular etiologies of MODY and other early-onset forms of diabetes

14. Liver X receptors as potential drug targets for Diabetes and its disorders

15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis

16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys

17. PPARgamma and metabolism: Insights from the study of human genetic variants

Product details

  • Edition: 1
  • Latest edition
  • Volume: 5
  • Published: August 10, 2006
  • Language: English

About the editor

JF

Jacob E. Friedman

Affiliations and expertise
University of Colorado Health Sciences Center, Denver, CO, USA

View book on ScienceDirect

Read New Transcription Factors and Their Role in Diabetes and Therapy on ScienceDirect